Administration of 51W89 by infusion--a comparison with atracurium--preliminary communication.
Mellinghoff
H
H
Institut für Anästhesiologie, Universität zu Köln, Cologne, Germany.
Diffenbach
C
C
Buzello
W
W
D000762:Anesthesia Recovery Period; D000769:Anesthesia, Inhalation; D001279:Atracurium / Q000008:administration & dosage* / Q000037:antagonists & inhibitors; D001285:Atropine / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D006801:Humans; D007262:Infusions, Intravenous; D007546:Isoquinolines / Q000008:administration & dosage* / Q000037:antagonists & inhibitors; D018727:Muscarinic Antagonists / Q000627:therapeutic use; D009119:Muscle Contraction / Q000187:drug effects; D018482:Muscle, Skeletal / Q000187:drug effects; D009388:Neostigmine / Q000627:therapeutic use; D003473:Neuromuscular Nondepolarizing Agents / Q000008:administration & dosage* / Q000037:antagonists & inhibitors; D013237:Stereoisomerism; D013997:Time Factors
D002800:Cholinesterase Inhibitors; D007546:Isoquinolines; D018727:Muscarinic Antagonists; D003473:Neuromuscular Nondepolarizing Agents; D001279:Atracurium; D009388:Neostigmine; D001285:Atropine